Dome Gold Mines (DME) Q1 2027 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 TU earnings summary
30 Oct, 2026Executive summary
Sigatoka draft EIA entered a statutory 21-day public review ending 30 October 2026, followed by public meetings in Sigatoka on 6–7 November.
Exploration resumption plans advanced for Nadrau, while relinquishment of Ono Island licence SPL1451 was completed.
Securities remained suspended pending completion of the FY2026 audit; quarter-end cash was nil and operations relied on loan facilities.
Financial highlights
Q1 operating cash outflow was $202k, investing cash outflow $48k and financing cash inflow $250k; reported quarter-end cash was nil.
Exploration and related expenditure totaled $45k, including ~$34k for the Sigatoka feasibility-study program; no mining production or development expenditure was incurred.
Related-party payments totaled $10k, comprising directors’ fees and superannuation guarantee.
Outlook and guidance
Sigatoka EIA assessment will proceed after public review and consideration of submitted comments; DOE will determine next steps.
Final Sigatoka feasibility-study work is intended to support study sign-off and a Mining Lease application.
Planned Nadrau work includes airborne geophysics over anomalous copper, gold and silver geochemistry to focus future exploration and drilling.
Latest events from Dome Gold Mines
- Feasibility study at Sigatoka advances as funding and exploration efforts intensify.DME
Q4 2026 TU - Sigatoka feasibility advances, Nadrau exploration to resume, $3M funding sought for next steps.DME
Q3 2026 TU - Sigatoka project targets fast, low-cost production of premium sand and magnetite for Fiji and export.DME
Company presentation - Nadrau Project exhibits strong porphyry Cu-Au potential with major exploration upside.DME
Corporate presentation - Feasibility and EIA for Sigatoka advanced; $5.5M raised; net loss $4.6M; going concern risk.DME
H2 2025 - Feasibility and EIA for Sigatoka advanced; net loss narrows; funding and going concern risks persist.DME
H2 2024 - Net loss widened and cash reserves dropped as project progress hinges on new funding.DME
H1 2026 - Sigatoka Feasibility Study advanced; $314K cash and 7 quarters of funding available.DME
Q1 2026 TU - Sigatoka feasibility study advanced amid delays; strong cash and financing position maintained.DME
Q4 2025 TU